{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361699996200230144.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1053/j.gastro.2005.11.016"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0016508505022766?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0016508505022766?httpAccept=text/plain"}},{"identifier":{"@type":"NAID","@value":"30023001428"}}],"dc:title":[{"@value":"Predicting Cirrhosis Risk Based on the Level of Circulating Hepatitis B Viral Load"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1381699996200230148","@type":"Researcher","foaf:name":[{"@value":"Uchenna H. Iloeje"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699996200230145","@type":"Researcher","foaf:name":[{"@value":"Hwai–I. Yang"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699996200230144","@type":"Researcher","foaf:name":[{"@value":"Jun Su"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699996200230149","@type":"Researcher","foaf:name":[{"@value":"Chin–Lan Jen"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699996200230146","@type":"Researcher","foaf:name":[{"@value":"San–Lin You"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699996200230147","@type":"Researcher","foaf:name":[{"@value":"Chien–Jen Chen"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00165085"}],"prism:publicationName":[{"@value":"Gastroenterology"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2006-03","prism:volume":"130","prism:number":"3","prism:startingPage":"678","prism:endingPage":"686"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S0016508505022766?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S0016508505022766?httpAccept=text/plain"}],"createdAt":"2006-03-14","modifiedAt":"2019-01-17","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050845763844328192","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Guidelines for avoiding risks resulting from discontinuation of nucleoside/nucleotide analogs in patients with chronic hepatitis B"},{"@value":"Guidelines for avoiding risks resulting from discontinuation of nucleoside/nucleotide analogs in patients with chronic hepatitis <scp>B</scp>"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004230187290880","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Correlation between pretreatment viral sequences and the emergence of lamivudine resistance in hepatitis B virus infection"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004232280670208","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Long-term use of entecavir in nucleoside-naïve Japanese patients with chronic hepatitis B infection"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004235757163264","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Management of hepatitis B: Consensus of the Japan Society of Hepatology 2009"}]},{"@id":"https://cir.nii.ac.jp/crid/1360005516525941632","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The Impact of Rapid Evolution of Hepatitis Viruses"}]},{"@id":"https://cir.nii.ac.jp/crid/1360013168880827008","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Serum PreS1 and HBsAg ratio reflects liver fibrosis and predicts the development of hepatocellular carcinoma in chronic hepatitis B patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285709455816704","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Studies of Efficacy and Liver Toxicity Related to Adeno-Associated Virus–Mediated RNA Interference"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285709456608384","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Long-Term Outcome of Sequential Therapy with Lamivudine Followed by Interferon-β in Nucleoside-Naive, Hepatitis B e-Antigen-Positive Patients with Chronic Hepatitis B Virus Genotype C Infection"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285710756364160","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Hepatitis B virus core‐related antigen levels predict progression to liver cirrhosis in hepatitis B carriers"}]},{"@id":"https://cir.nii.ac.jp/crid/1360298757420671744","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Outcome of nucleos(t)ide analog cessation in patients with treatment for prevention of or against hepatitis B virus reactivation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565168116348928","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"JSH Guidelines for the Management of Hepatitis B Virus Infection"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567185478951424","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Risk factors for exacerbation of gastroesophageal varices and portosystemic encephalopathy during treatment with nucleos(t)ide analogs for hepatitis B virus‐related cirrhosis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848656190200320","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Entecavir and interferon-α sequential therapy in Japanese patients with hepatitis B e antigen-positive chronic hepatitis B"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848656191275648","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The prognosis of hepatitis B inactive carriers in Japan: a multicenter prospective study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848657338505728","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Change in skeletal muscle mass after administering entecavir in patients with hepatitis B"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848660687481088","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Combination of hepatitis B viral antigens and DNA for prediction of relapse after discontinuation of nucleos(t)ide analogs in patients with chronic hepatitis B"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204792984064","@type":"Article","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"日本肝臓学会コンセンサス神戸2009：C型肝炎の診断と治療"},{"@language":"en","@value":"JSH Consensus Kobe 2009: Diagnosis and Treatment of Hepatitis C"},{"@language":"ja-Kana","@value":"ニホン カンゾウ ガッカイ コンセンサス コウベ 2009 Cガタ カンエン ノ シンダン ト チリョウ"},{"@value":"日本肝臓学会コンセンサス神戸2009--B型肝炎の診断と治療"},{"@language":"ja-Kana","@value":"ニホン カンゾウ ガッカイ コンセンサス コウベ 2009 Bガタ カンエン ノ シンダン ト チリョウ"},{"@value":"JSH Consensus Kobe 2009: Diagnosis and Treatment of Hepatitis B"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204793861376","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Guidelines for avoiding risks resulting from discontinuation of nucleos(t)ide analogues in patients with chronic hepatitis B (2012)"},{"@language":"ja","@value":"核酸アナログ薬中止に伴うリスク回避のための指針2012―厚生労働省「B型肝炎の核酸アナログ薬治療における治療中止基準の作成と治療中止を目指したインターフェロン治療の有用性に関する研究」の報告―"},{"@language":"ja-Kana","@value":"カクサン アナログヤク チュウシ ニ トモナウ リスク カイヒ ノ タメ ノ シシン 2012 : コウセイ ロウドウショウ 「 Bガタ カンエン ノ カクサン アナログヤク チリョウ ニ オケル チリョウ チュウシ キジュン ノ サクセイ ト チリョウ チュウシ オ メザシタ インターフェロン チリョウ ノ ユウヨウセイ ニ カンスル ケンキュウ 」 ノ ホウコク"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206399126784","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Indication of antiviral therapy for chronic hepatitis B"},{"@language":"ja","@value":"Ｂ型慢性肝炎の治療－Ｂ型肝炎治療のコンセンサスミーティングから"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206447135488","@type":"Article","resourceType":"other","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"7. Cutting Edge of the Treatment for Viral Hepatitis"},{"@language":"ja","@value":"7．ウイルス性肝炎の治療の進歩"},{"@value":"教育講演 ウイルス性肝炎の治療の進歩"},{"@language":"ja-Kana","@value":"キョウイク コウエン ウイルスセイ カンエン ノ チリョウ ノ シンポ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679771619840","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Two cases of acute hepatitis due to hepatitis E virus that are indigenous to Kitakyushu: a case report"},{"@language":"ja","@value":"北九州に土着したE型肝炎ウイルス株による急性肝炎の2例"},{"@value":"B型肝炎治療ガイドライン(第1.1版)"},{"@language":"ja-Kana","@value":"Bガタ カンエン チリョウ ガイドライン(ダイ1.1ハン)"},{"@language":"ja-Kana","@value":"キタキュウシュウ ニ ドチャク シタ Eガタ カンエンウイルスカブ ニ ヨル キュウセイ カンエン ノ 2レイ"},{"@value":"Guidelines for the management of hepatitis B virus infection"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1053/j.gastro.2005.11.016"},{"@type":"CIA","@value":"30023001428"},{"@type":"CROSSREF","@value":"10.1002/jmv.23314_references_DOI_H6DINvw0RWF0YYIn2WNDlrh0Sn9"},{"@type":"CROSSREF","@value":"10.1111/j.1872-034x.2010.00739.x_references_DOI_H6DINvw0RWF0YYIn2WNDlrh0Sn9"},{"@type":"CROSSREF","@value":"10.1111/jvh.13557_references_DOI_H6DINvw0RWF0YYIn2WNDlrh0Sn9"},{"@type":"CROSSREF","@value":"10.1089/hum.2012.239_references_DOI_H6DINvw0RWF0YYIn2WNDlrh0Sn9"},{"@type":"CROSSREF","@value":"10.1089/jir.2014.0234_references_DOI_H6DINvw0RWF0YYIn2WNDlrh0Sn9"},{"@type":"CROSSREF","@value":"10.1111/hepr.12108_references_DOI_H6DINvw0RWF0YYIn2WNDlrh0Sn9"},{"@type":"CROSSREF","@value":"10.1111/jgh.13989_references_DOI_H6DINvw0RWF0YYIn2WNDlrh0Sn9"},{"@type":"CROSSREF","@value":"10.1016/j.jhep.2009.12.036_references_DOI_H6DINvw0RWF0YYIn2WNDlrh0Sn9"},{"@type":"CROSSREF","@value":"10.2957/kanzo.51.243_references_DOI_H6DINvw0RWF0YYIn2WNDlrh0Sn9"},{"@type":"CROSSREF","@value":"10.2957/kanzo.53.237_references_DOI_H6DINvw0RWF0YYIn2WNDlrh0Sn9"},{"@type":"CROSSREF","@value":"10.1016/b978-0-12-374153-0.00015-1_references_DOI_H6DINvw0RWF0YYIn2WNDlrh0Sn9"},{"@type":"CROSSREF","@value":"10.1111/hepr.13864_references_DOI_H6DINvw0RWF0YYIn2WNDlrh0Sn9"},{"@type":"CROSSREF","@value":"10.1111/hepr.12269_references_DOI_H6DINvw0RWF0YYIn2WNDlrh0Sn9"},{"@type":"CROSSREF","@value":"10.1111/hepr.12996_references_DOI_H6DINvw0RWF0YYIn2WNDlrh0Sn9"},{"@type":"CROSSREF","@value":"10.1007/s00535-012-0645-5_references_DOI_H6DINvw0RWF0YYIn2WNDlrh0Sn9"},{"@type":"CROSSREF","@value":"10.1007/s00535-016-1229-6_references_DOI_H6DINvw0RWF0YYIn2WNDlrh0Sn9"},{"@type":"CROSSREF","@value":"10.1111/j.1872-034x.2011.00910.x_references_DOI_H6DINvw0RWF0YYIn2WNDlrh0Sn9"},{"@type":"CROSSREF","@value":"10.2957/kanzo.54.402_references_DOI_H6DINvw0RWF0YYIn2WNDlrh0Sn9"},{"@type":"CROSSREF","@value":"10.2169/naika.101.2681_references_DOI_H6DINvw0RWF0YYIn2WNDlrh0Sn9"},{"@type":"CROSSREF","@value":"10.1016/j.nut.2015.04.003_references_DOI_H6DINvw0RWF0YYIn2WNDlrh0Sn9"}]}